(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1347584 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PARP9 mRNA CTD PMID:22079256 1,2-dimethylhydrazine multiple interactions ISO RGD:1552550 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PARP9 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PARP9 mRNA CTD PMID:17557909 17beta-estradiol decreases expression ISO RGD:1347584 6480464 Estradiol results in decreased expression of PARP9 mRNA CTD PMID:20106945 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PARP9 mRNA CTD PMID:26496021 17beta-estradiol increases expression ISO RGD:1347584 6480464 Estradiol results in increased expression of PARP9 mRNA CTD PMID:21185374 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1347584 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1552550 6480464 2 more ... CTD PMID:30294300 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO RGD:1552550 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1552550 6480464 Tetrachlorodibenzodioxin results in increased expression of PARP9 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PARP9 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1347584 6480464 Tetrachlorodibenzodioxin results in increased expression of PARP9 mRNA CTD PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1552550 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PARP9 promoter] CTD PMID:19654925 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of PARP9 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide decreases expression ISO RGD:1552550 6480464 Fenretinide results in decreased expression of PARP9 mRNA CTD PMID:28973697 acetamide increases expression EXP 6480464 acetamide results in increased expression of PARP9 mRNA CTD PMID:31881176 all-trans-retinoic acid increases expression ISO RGD:1347584 6480464 Tretinoin results in increased expression of PARP9 mRNA CTD PMID:23830798 , PMID:33167477 antirheumatic drug decreases expression ISO RGD:1347584 6480464 Antirheumatic Agents results in decreased expression of PARP9 mRNA CTD PMID:24449571 aristolochic acid increases expression ISO RGD:1347584 6480464 aristolochic acid I results in increased expression of PARP9 protein CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1347584 6480464 arsenite inhibits the reaction [G3BP1 protein binds to PARP9 protein] CTD PMID:32406909 belinostat decreases expression ISO RGD:1347584 6480464 belinostat results in decreased expression of PARP9 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO RGD:1552550 6480464 Benzo(a)pyrene results in decreased expression of PARP9 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:1347584 6480464 Benzo(a)pyrene results in decreased expression of PARP9 mRNA CTD PMID:30453624 benzo[a]pyrene increases methylation ISO RGD:1552550 6480464 Benzo(a)pyrene results in increased methylation of PARP9 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1552550 6480464 Benzo(a)pyrene results in increased expression of PARP9 mRNA CTD PMID:23735875 benzo[a]pyrene increases expression ISO RGD:1347584 6480464 Benzo(a)pyrene results in increased expression of PARP9 mRNA CTD PMID:20106945 , PMID:21632981 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PARP9 mRNA CTD PMID:26496021 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PARP9 mRNA CTD PMID:30816183 more ... bisphenol A increases expression ISO RGD:1347584 6480464 bisphenol A results in increased expression of PARP9 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PARP9 gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PARP9 mRNA CTD PMID:25181051 butanal decreases expression ISO RGD:1347584 6480464 butyraldehyde results in decreased expression of PARP9 mRNA CTD PMID:26079696 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PARP9 mRNA CTD PMID:25993096 carbon nanotube increases expression ISO RGD:1552550 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1347584 6480464 CGP 52608 promotes the reaction [RORA protein binds to PARP9 gene] CTD PMID:28238834 chromium(6+) affects expression ISO RGD:1552550 6480464 chromium hexavalent ion affects the expression of PARP9 mRNA CTD PMID:28472532 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PARP9 mRNA CTD PMID:17602206 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of PARP9 mRNA CTD PMID:24386269 copper(II) sulfate decreases expression ISO RGD:1347584 6480464 Copper Sulfate results in decreased expression of PARP9 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of PARP9 mRNA CTD PMID:26577399 , PMID:27523638 cyclosporin A decreases expression ISO RGD:1347584 6480464 Cyclosporine results in decreased expression of PARP9 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:1552550 6480464 Cyclosporine results in decreased expression of PARP9 mRNA CTD PMID:19770486 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PARP9 mRNA CTD PMID:33729688 dorsomorphin multiple interactions ISO RGD:1347584 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PARP9 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1347584 6480464 Doxorubicin results in decreased expression of PARP9 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PARP9 mRNA CTD PMID:29391264 ethanol affects expression ISO RGD:1552550 6480464 Ethanol affects the expression of PARP9 mRNA CTD PMID:26730594 ethyl methanesulfonate increases expression ISO RGD:1347584 6480464 Ethyl Methanesulfonate results in increased expression of PARP9 mRNA CTD PMID:23649840 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PARP9 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:1552550 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PARP9 mRNA CTD PMID:22206623 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PARP9 mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PARP9 mRNA CTD PMID:33387578 hydrogen peroxide affects expression ISO RGD:1347584 6480464 Hydrogen Peroxide affects the expression of PARP9 mRNA CTD PMID:20044591 hydroquinone decreases expression ISO RGD:1347584 6480464 hydroquinone results in decreased expression of PARP9 mRNA CTD PMID:31256213 Licochalcone B decreases expression ISO RGD:1347584 6480464 licochalcone B results in decreased expression of PARP9 mRNA CTD PMID:33647349 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of PARP9 mRNA CTD PMID:30467583 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:1552550 6480464 Ethylnitrosourea results in increased mutagenesis of PARP9 gene CTD PMID:27776689 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of PARP9 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PARP9 mRNA CTD PMID:17602206 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of PARP9 mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:1347584 6480464 Nickel results in decreased expression of PARP9 mRNA CTD PMID:23195993 nickel atom increases expression ISO RGD:1347584 6480464 Nickel results in increased expression of PARP9 mRNA CTD PMID:25583101 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PARP9 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1552550 6480464 Acetaminophen affects the expression of PARP9 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PARP9 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1347584 6480464 Acetaminophen results in decreased expression of PARP9 mRNA CTD PMID:21420995 more ... pentachlorophenol increases expression ISO RGD:1552550 6480464 Pentachlorophenol results in increased expression of PARP9 mRNA CTD PMID:23892564 phenylmercury acetate multiple interactions ISO RGD:1347584 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PARP9 mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO RGD:1552550 6480464 pirinixic acid results in decreased expression of PARP9 mRNA CTD PMID:17426115 potassium chromate decreases expression ISO RGD:1347584 6480464 potassium chromate(VI) results in decreased expression of PARP9 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1347584 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PARP9 mRNA CTD PMID:22079256 resveratrol multiple interactions ISO RGD:1347584 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of PARP9 mRNA CTD PMID:23557933 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PARP9 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1347584 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PARP9 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1347584 6480464 Silicon Dioxide analog results in decreased expression of PARP9 mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:1552550 6480464 Silver results in decreased expression of PARP9 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1552550 6480464 Silver results in decreased expression of PARP9 mRNA CTD PMID:27131904 sodium arsenate increases expression ISO RGD:1552550 6480464 sodium arsenate results in increased expression of PARP9 mRNA CTD PMID:30953684 sodium arsenite decreases expression ISO RGD:1347584 6480464 sodium arsenite results in decreased expression of PARP9 protein CTD PMID:30528433 Soman increases expression EXP 6480464 Soman results in increased expression of PARP9 mRNA CTD PMID:19281266 tamoxifen affects expression ISO RGD:1552550 6480464 Tamoxifen affects the expression of PARP9 mRNA CTD PMID:20937368 temozolomide increases expression ISO RGD:1347584 6480464 Temozolomide results in increased expression of PARP9 mRNA CTD PMID:31758290 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PARP9 mRNA CTD PMID:31150632 titanium dioxide increases expression ISO RGD:1552550 6480464 titanium dioxide results in increased expression of PARP9 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PARP9 mRNA CTD PMID:25729387 triclosan increases expression ISO RGD:1347584 6480464 Triclosan results in increased expression of PARP9 mRNA CTD PMID:30510588 Triptolide increases expression EXP 6480464 triptolide results in increased expression of PARP9 protein CTD PMID:32519852 urethane decreases expression ISO RGD:1347584 6480464 Urethane results in decreased expression of PARP9 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1347584 6480464 Valproic Acid results in decreased expression of PARP9 mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:1347584 6480464 Valproic Acid affects the expression of PARP9 mRNA CTD PMID:25979313 vancomycin decreases expression ISO RGD:1552550 6480464 Vancomycin results in decreased expression of PARP9 mRNA CTD PMID:18930951 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of PARP9 promoter CTD PMID:20927350 vincristine increases expression ISO RGD:1347584 6480464 Vincristine results in increased expression of PARP9 mRNA CTD PMID:23649840 zidovudine multiple interactions ISO RGD:1347584 6480464 [Zidovudine co-treated with IFNA1 protein] results in increased expression of PARP9 mRNA CTD PMID:20370541